SLSR
Solaris·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 2
Consensus Rating "Strong Buy"
Ample Liquidity
Price Hits New Low
Price Hits 52-week Low
Bullish Abandoned Baby
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SLSR
Solaris Resources Inc.
A mining company registered in Canada, specializing in the exploration and development of mineral resources in Ecuador
7 Times Square, Suite 2503, New York, NY 10036
--
Solaris Resources Inc. was founded in Canada. Solaris is a late-stage clinical biopharmaceutical company focused on developing new treatments for a wide range of cancer indications. The company's product candidates currently include galinpepimuts (GPS), a peptide immunotherapy targeting the Wilms tumor 1 (WT1) antigen, and SLS009 (formerly known as GFH009), a highly selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor.
Company Financials
EPS
SLSR has released its 2025 Q3 earnings. EPS was reported at -0.07, versus the expected -0.1, beating expectations. The chart below visualizes how SLSR has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
